Loss of wild type KRAS in KRASMUT lung adenocarcinoma is associated with cancer mortality and confers sensitivity to FASN inhibitors

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Loss of wild type KRAS in KRAS<sup>MUT</sup> lung adenocarcinoma is associated with cancer mortality and confers sensitivity to FASN inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences